Item | Sow treatment | Post-weaning dietary treatment | |||||||
---|---|---|---|---|---|---|---|---|---|
Control | Xylanase3 | SEM | P-value | Control | Xylanase | Stimbiotic3 | SEM | P-value | |
Phase 1 (d 1 to 14) | |||||||||
Initial body weight, kg | 5.77 | 5.84 | 0.20 | 0.589 | 5.81 | 5.83 | 5.77 | 0.21 | 0.924 |
ADG4, g | 97.44 | 83.95 | 10.79 | 0.196 | 102.40 | 85.17 | 84.54 | 11.65 | 0.235 |
ADFI4, g | 171.90 | 171.60 | 8.28 | 0.979 | 182.10 | 165.30 | 167.90 | 8.28 | 0.294 |
G:F4 | 0.54 | 0.49 | 0.05 | 0.187 | 0.56 | 0.50 | 0.50 | 0.06 | 0.308 |
Final body weight, kg | 7.13 | 7.02 | 0.24 | 0.555 | 7.25 | 7.02 | 6.96 | 0.26 | 0.395 |
Phase 2 (d 15 to 28) | |||||||||
ADG, g | 430.60 | 440.50 | 15.54 | 0.542 | 391.70b | 434.70b | 480.20a | 16.99 | < 0.001 |
ADFI, g | 654.20 | 666.40 | 22.11 | 0.632 | 652.10 | 663.80 | 665.10 | 24.60 | 0.885 |
G:F | 0.66 | 0.66 | 0.01 | 0.867 | 0.60c | 0.66b | 0.73a | 0.01 | < 0.001 |
Final body weight, g | 13.17 | 13.18 | 0.45 | 0.973 | 12.73y | 13.11xy | 13.68x | 0.47 | 0.073 |
Phase 3 (d 29 to 42) | |||||||||
ADG, g | 618.10 | 626.10 | 14.95 | 0.701 | 566.80b | 648.30a | 651.20a | 17.25 | 0.001 |
ADFI, g | 1,054.10 | 1,037.40 | 26.90 | 0.577 | 1,001.10y | 1,071.40xy | 1,064.60x | 29.73 | 0.084 |
G:F | 0.59 | 0.61 | 0.02 | 0.310 | 0.57y | 0.61x | 0.62x | 0.02 | 0.098 |
Final body weight, kg | 21.78 | 21.99 | 0.45 | 0.697 | 20.67b | 22.18a | 22.80a | 0.50 | 0.004 |
Overall (d 1 to 42) | |||||||||
ADG, g | 381.70 | 383.90 | 8.72 | 0.851 | 353.60b | 389.40a | 405.30a | 10.04 | 0.001 |
ADFI, g | 626.10 | 625.80 | 11.19 | 0.983 | 611.80 | 633.50 | 632.50 | 13.71 | 0.455 |
G:F | 0.61 | 0.62 | 0.02 | 0.441 | 0.58b | 0.61a | 0.64a | 0.02 | < 0.001 |